Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects
Author:
Funder
Natural Science Foundation of Liaoning Province
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference150 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
2. Metallic nanoparticle-mediated immune cell regulation and advanced cancer immunotherapy;Mohapatra;Pharmaceutics,2021
3. Cancer immunotherapy: the beginning of the end of cancer?;Farkona;BMC Med.,2016
4. Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: a phase 1 study;Emens;JAMA Oncol.,2019
5. A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis;Brufsky;Ann. Oncol.,2021
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research progress in tumor therapy of carrier-free nanodrug;Biomedicine & Pharmacotherapy;2024-09
2. Developing oxaliplatin and IL-15 Co-carried gels as drug depots to enable triple-interlocked combination therapy for colorectal cancer;Colloids and Surfaces B: Biointerfaces;2024-09
3. Exploring the therapeutic modalities of targeted treatment approach for skin carcinoma: cutting-edge strategies and key insights;Expert Opinion on Drug Delivery;2024-08-19
4. Recent Advances in Photodynamic Therapy: Metal-Based Nanoparticles as Tools to Improve Cancer Therapy;Pharmaceutics;2024-07-12
5. Salt Tolerant Microbes (Active Metabolites) Mediated Nanoparticle: Drug Delivery and Future Prospects;Journal of Pure and Applied Microbiology;2024-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3